Biotech Values

[iwfal]

Best critique I've seen. TLDR: the propensity score matching didn't control for severity of T2D (eg duration of disease, other treatments, HbA1c) and Ozempic isn't first line treatment. So by definition the more severe diabetics were more likely to get Ozmpic

DO GLP-1 Agonists Really Cause Eye Disease

There has been a huge amount of press about a report showing an association between the use of GLP-1 agonists and Nonarteritic anterior ischemic optic neuropathy (NAION)https://t.co/unSdVTE6Zs

Because of it being heavily promoted by… pic.twitter.com/fHeVn9LBJr

— Ed Livingston (@ehlJAMA) July 7, 2024